Genzyme, a pioneer in the development and delivery of transformative therapies for over 30 years, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years.
Headquarters: Massachusetts, USA
Ticker Symbol: GEZ (Frankfurt Stock Exchange) GENZ (Nasdaq Stock Exchange)
SEC Link: Genzyme
The remaining part of this article is Premium content – see below for access options.
CP Insight – Premium content section
This is a premium content section and requires a paid subscription to access.